Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

SpectraCure has registered the trademark Q-PRO[®]

SpectraCure AB (publ) has obtained trademark protection for Q-PRO[®], the name of the new generation system, in Europe and in the USA. Applications to register the trademark have been submitted in Australia, China and Japan.[En bild som visar text, dator, bord Automatiskt genererad beskrivning] SpectraCure is developing a system for treatment of recurrent prostate cancer. The system is currently used in a clinical study in Canada, the United States, and the United Kingdom. The name of the system, Q-PRO[®], has now received trademark protection. The trademark protection means that the

Handheld launches new ultra-rugged 10-inch Windows tablet with 5G

Handheld Group, a leading manufacturer of rugged mobile computers, today announced the release of the all-new Algiz 10XR, an ultra-rugged 10-inch Windows tablet that combines durability with robust field performance, 5G and future-proof features.The Algiz 10XR  is a smaller, lighter, 10-inch Windows tablet that achieves more even while taking up less space. It brings two times better graphics and measurably faster performance.

BioStock: Ultimovacs shows positive three-year data in skin cancer

Norwegian biotech Ultimovacs has recently presented positive three-year data for patients with metastatic malignant melanoma treated with cancer vaccine UV1 in combination with anti-PD-1 checkpoint inhibitor pembrolizumab. The results show both promising overall survival and an effect on predictive biomarkers, which strengthens the company's belief in UV1 as a combination treatment with today's checkpoint inhibitors for solid tumours. BioStock contacted Espen Basmo Ellingsen, Director Medical Affairst Ultimovacs, to find out more.Read interview with Espen Basmo Ellingsen at biostock.se:

Friskis & Svettis to open on Bruksgatan in Mölnlycke Fabrike

Early next fall, Friskis & Svettis will move to new premises in Mölnlycke Fabriker. Then all members will be welcomed to a newly renovated premises of 1,400 square meters right in the heart of the district. With an entrance from Bruksgatan, a pleasant thoroughfare that runs through Mölnlycke Fabriker, the location will be more publicly and easily accessible for both local residents and visitors.“We are happy that Friskis & Svettis is choosing to continue expanding along with us in Mölnlycke Fabriker. They have been in the area for a long time and add a nice value to the overall district.

Webstep ASA: Invitation to presentation of financial reports Q3 2022

Oslo, 3 November 2022:  Please note that Webstep ASA will announce its third quarter 2022 results 10 November 2022.The presentation will be available via the following webcast link at 9:00 am CET the same day: https://channel.royalcast.com/landingpage/hegnarmedia/20221109_3/ The interim report and presentation will be available from 7:00 am CET the same day at: https://investor.webstep.com/Investors/reports-and-presentations/default.aspx

William Osler Health System in Canada scales into an enterprise imaging agreement with Sectra

Linköping, Sweden and Mississauga, ON – November 3, 2022 – International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) and William Osler Health System (Osler) have signed a contract to expand their orthopaedic solution to include radiology imaging, breast imaging, and Sectra’s vendor-neutral archive (VNA), scaling into a new enterprise imaging agreement. This expansion will enable efficient workflows and collaboration to provide high-quality patient care across the Peel and North Etobicoke regions of Ontario, Canada.Osler has three sites: Brampton

Sound Bioventures sees increased investment opportunities

Valuations in the public life science market continue to decline and companies in the sector are becoming increasingly attractive to investors. The VC fund Sound Bioventures is now expanding its investment strategy to also invest in listed companies in the life science industry, from only focusing on private companies. BioStock spoke with Johan Kördel, Managing Partner at Sound Bioventures, about the company’s new investment strategy.Read the full article at biostock.se:https://www.biostock.se/en/2022/11/sound-bioventures-sees-increased-investment-opportunities/ This is a press release

Nordnet: Monthly statistics October

In October, 4,164,600 trades were made in listed financial instruments among Nordnet’s customers, which corresponds to 198,300 trades per day. The net change in the customer base in October was 11,000 customers. The number of new customers in 2022 is 139,200 gross and 87,500 net. The latter figure includes the customer relationships terminated as a result of the completed project on obtaining complete customer documentation as described in Nordnet’s interim report for the third quarter of 2021. The total number of customers at the end of October was 1,688,500. Net savings for October was

Invitation to presentation of Pagero’s interim report for Q3 2022

Pagero Group AB (publ) publishes interim report for January – September 2022 on 10 November 2022 at 07.30 CET and invites to a presentation of the report at 08.00 CET on the same day.Bengt Nilsson, CEO of Pagero, will present Pagero’s first half year in a webcast. It will be possible to submit questions in writing during the presentation, which will be answered at the end of the broadcast. Follow the presentation live: Link  For more informationBengt Nilsson, CEOBengt.nilsson@pagero.com Jan-Olof Ohlsson, CFOJan-olof.

Moberg Pharma’s nomination committee appointed

STOCKHOLM, November 3[rd], 2022 – In accordance with the resolution of the Annual General Meeting on May 16[th], 2022, the Chairman of the Board has contacted the company’s three largest shareholders or group of shareholders in terms of votes to form a Nomination Committee. These shareholders have been invited to appoint one representative each who, together with the Chairman of the Board, will comprise the Nomination Committee. As not all of the company’s three largest shareholders or group of shareholders have wished to appoint such representative, the fourth largest shareholder/group of

Q3 Report 2022 – invitation to conference call and audiocast

Stockholm, November 3, 2022 - On Thursday, November 10, at 09.00 CET, IRRAS will host a conference call and an online presentation of its Q3 2022 interim report (which will have been published earlier on November 10 at 08.00 CET). The presentation will be held in English. The dial-in numbers for the conference call are:Sweden: +46 8 50 51 63 86UK: +44 203 198 4884US: +1 412 317 6300Pin code: 8057017# The presentation will be webcast and can be accessed from the following web address: https://tv.streamfabriken.com/irras-q3-2022 Speakers: President and CEO Will Martin,

MEDIVIR AB – INTERIM REPORT JANUARY – SEPTEMBER 2022

The measures to increase the pace of patient recruitment have yielded results. The Fostrox study is now progressing as expected.July – SeptemberFinancial summary for the quarter · Net turnover amounted to SEK 1.1 (0.8) million. · The loss before interest, tax, depreciation and amortization (EBITDA) amounted to SEK -13.9 (-11.7) million. Basic and diluted earnings per share amounted to SEK -0.27 (-0.24) and SEK -0.27 (-0.24) respectively. · Cash flow from operating activities amounted to SEK -19.7 (-20.0) million. · Cash and cash equivalents at the end of the period

Quarterly Report Quartiers Properties – July to September 2022

Quartiers Properties AB (publ) has today published the company’s quarterly report for the period July to September 2022.The company's best ever quarter, with EBITDA of SEK 7,556 thousand. July–September 2022: · Net sales in the third quarter were SEK 78,385 (70,574) thousand. Of net sales, apartment sales accounted for SEK 40,219 (42,095) thousand and income from operating activities for SEK 38,166 (28,479) thousand. · The company’s operating cash flow, including property sales, was SEK 23,882 (32,680) thousand. Cash flow from operating activities improved by SEK 5,222 thousand,

NORDEN reports net profit of USD 243 mill. and pays interim dividend to the shareholders

ANNOUNCEMENT NO. 229 - 3 NOVEMBER 2022   For Q3 2022 NORDEN reports a profit of USD 243 million (approx. DKK 1.9 bill.). Cash flow from operating activities amounts to approx. USD 399 mill. (approx. DKK 3 bill.). Return on equity at 64% at end of Q3.   NORDEN CEO, Jan Rindbo, comments: “NORDEN’s third quarter net profit of USD 243 million and 64% return on equity is a testimony to our unique trading model. During the quarter, NORDEN generated high dry cargo earnings in a weakening market. In addition, our large exposure to tankers enabled NORDEN to capitalise on surging

New report lays out the case for a just transition in meat production and consumption

An SEI analysis maps out key stakeholders and identifies guiding principles for building healthier, more sustainable food systems. The world’s appetite for meat continues to grow, with profound implications for the environment, human health and animal welfare. The production of animal-based foods has been found to be responsible for at least 16.5% of total greenhouse gas emissions. If meat consumption continues on current trends, scientists have found, it will be impossible to keep global warming below 1.5°C, and difficult to stay below 2°C. The sector is also a key

Wyld Networks and Lacuna Space agree partnership, boosting the number of operational satellites within Wyld’s virtual satellite IoT service

Wyld Networks has announced a partnership with Lacuna Space to increase global satellite coverage and capacity for its commercial sensor-to-satellite service to be launched in December 2022.The agreement will allow Wyld to transfer data from its low-power, sensor-to-satellite LoRaWAN® terminals and modules through Lacuna’s network of Low Earth Orbiting (LEO) satellites for IoT applications where there is little or no alternative connectivity. With 100 percent global coverage, satellite IoT is ideal for applications in remote areas from agriculture and environmental monitoring, supply

Ahlstrom invests in South America to support filtration customers with a new lamination capability

AHLSTROM, PRESS RELEASE, NOVEMBER 3, 2022 at 09:00 EET Ahlstrom perpetuates its 50-year commitment and support to the global Filtration industry by investing EUR 2 million in a new laminator at Louveira plant, Brazil. With a planned installation in 2023, the equipment is expected to be fully operational by Q1 2024.     This strategic growth initiative will expand manufacturing capabilities at Louveira plant. It reinforces our ambition in local and regional filtration markets by offering customers shorter lead-times and improved local technical support. “Along with optimizing the

Exel Composites' Business Review Q1-Q3 2022: Good revenue and ebit improvement in Q3 2022

EXEL COMPOSITES PLC      STOCK EXCHANGE RELEASE      3 November 2022 at 09:00 EETQ3 2022 in brief · Order intake decreased by 0.3% to EUR 24.5 million (Q3 2021: 24.6). · Revenue increased by 1.2% to EUR 33.8 million (33.4). · Operating profit increased to EUR 1.7 million (-1.7), which is 5.0% of revenue (-5.1). · Adjusted operating profit increased to EUR 1.8 million (0.1), which is 5.4% of revenue (0.3). · Earnings per share amounted to EUR 0.18 (-0.19). Q1-Q3 2022 in brief · Order intake decreased by 10.0% to EUR 99.1 million (Q1-Q3 2021: 110.1). · Revenue

Metso Outotec to deliver solvent extraction technology to South America

Metso Outotec Corporation’s press release on November 3, 2022, at 09:00 a.m. EETMetso Outotec has been awarded a contract for the delivery of VSF® solvent extraction technology to South America. The order value of, approximately EUR 10 million, has been booked in Minerals’ fourth-quarter orders received. Metso Outotec’s scope of delivery includes engineering, proprietary and key equipment, spare parts, and advisory services for the mechanical installation as well as commissioning and start-up of the solvent extraction plant. Read more about solvent extraction 

CONCENTRIC INTERIM REPORT JANUARY – SEPTEMBER 2022

THIRD QUARTER 2022 · Net sales: MSEK 1,068 (515) – reported sales were up +107% year-on-year. After adjusting for the impact of currency +14% and EMP +84%, sales in constant currency year-on-year were up +9%. · Operating income: MSEK 175 (114), generating an Operating margin of 16.3% (22.2). Operating income in the third quarter includes the profit from the sale of our Argentine business of MSEK 9 leading to a Operating income before items affecting comparability of MSEK 166 (114). · Net income for the period: MSEK 126 (91); basic EPS of SEK 3.32 (2.39). · Cash flow from

Greenfood lists four-year sustainability-linked bond on Nasdaq Stockholm

In November 2021, Greenfood AB (publ) issued a four-year sustainability-linked bond of SEK 1,050,000,000. According to the agreement from the issue date, Greenfood has successfully listed this bond on Nasdaq Stockholm with first day of trading on November 3, 2022. More information and bond prospectus are available on Greenfood's website: https://www.greenfood.se/en/bond For more information, please contact:Mattias Engberg, CFO Greenfood Groupmattias.engberg@greenfood.se

Orexo Interim Report Q3 2022

Advancing the pipeline facilitating future growth Q3 2022 highlights · Total net revenues of SEK 161.0 m (145.9) · EBITDA of SEK -32.4 m (-47.4), EBITDA excluding legal costs and costs for non-repeating clinical trials, SEK 14.3 m (-13.4)  · Net earnings of SEK -26.5 m (-52.0) · US Pharma segment (ZUBSOLV[®] US) net revenues of SEK 150.1 m (136.4), in local currency USD 14.2 m (15.8), US Pharma EBIT of SEK 70.2 m (78.5) · Cash flow from operating activities of SEK -60.7 m (-79.7), cash and invested funds of SEK 443.9 m (588.1) a reduction of SEK 23,8 m from SEK 467.7 m

Optomed Plc: Interim report, January – September 2022

Optomed Plc Stock Exchange Release 3 November 2022 at 9.00, Helsinki    Optomed Plc: Interim report, January – September 2022 July – September 2022   · Revenue increased by 10.7 percent to EUR 3.7 (3.3) million. · Devices segment revenue increased by 45.4 percent to EUR 1.7 (1.2) million. The growth rate of the segment was 40.2% at comparable exchange rates. · In the Devices segment all sales channels but China came out with a solid performance. · Software segment revenue decreased by 7.9 percent to EUR 2.0 (2.2) million due to the segment focusing more on R&D. ·

Interim Report January – September 2022

Highlights“With a strong Group EBITDA margin of 7.3%, and a positive cash flow, we remain committed to and confident about delivering streaming revenue growth for 2022 within the previously communicated target range of 30–34% as well as our improved full-year Group EBITDA margin target in the range of 2.5–3%” says Johannes Larcher, CEO, Storytel.Financial highlights · Streaming revenue up 27% from Q3 2021 to 742 (583) MSEK, 29% excluding Russia  · Group net sales increased by 18% from Q3 2021 to 806 (681) MSEK  · Gross profit of 312 (280) MSEK, equaling a 38.7% margin (41.1%)

There are no items matching the current filter
There are no more items matching the current filter
Back to top